6.70
-0.90
(-11.84%)
As of 8:00:48 AM GMT+2. Market Open.
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XE9.BE | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
| Initiated | Wells Fargo: Overweight | 12/12/2024 |
| Upgrade | Piper Sandler: Neutral to Overweight | 12/2/2024 |
| Reiterates | BMO Capital: Outperform to Outperform | 11/8/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 11/7/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 9/26/2024 |
Related Tickers
LGDN.F Ligand Pharmaceuticals Incorporated
86.50
-4.42%
S09.F Sutro Biopharma, Inc.
0.5665
+13.19%
XOMA XOMA Royalty Corporation
18.76
-2.44%
PLX Protalix BioTherapeutics, Inc.
2.2800
-2.56%
CHRS Coherus BioSciences, Inc.
0.7713
-6.11%
HALO Halozyme Therapeutics, Inc.
57.54
-3.05%
BBIO BridgeBio Pharma, Inc.
30.14
-1.73%